DY Mason

1.7k total citations · 1 hit paper
13 papers, 1.3k citations indexed

About

DY Mason is a scholar working on Pathology and Forensic Medicine, Genetics and Immunology. According to data from OpenAlex, DY Mason has authored 13 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 5 papers in Genetics and 5 papers in Immunology. Recurrent topics in DY Mason's work include Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Acute Lymphoblastic Leukemia research (3 papers). DY Mason is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Acute Lymphoblastic Leukemia research (3 papers). DY Mason collaborates with scholars based in United Kingdom, Italy and Germany. DY Mason's co-authors include K C Gatter, Brunangelo Falini, Georges Delsol, H Stein, Margaret T. Jones, Johannes Gerdes, Gorm Pallesen, Nathan O’Connor, K. Lennert and Hilmar Lemke and has published in prestigious journals such as Blood, British Journal of Cancer and The Journal of Pathology.

In The Last Decade

DY Mason

13 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells

1985 568 citations H Stein, DY Mason et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
DY Mason United Kingdom	10	770	458	438	266	242	13	1.3k
CM Spier United States	12	915 1.2×	716 1.6×	326 0.7×	378 1.4×	275 1.1×	15	1.5k
Lawrence W. Diamond United States	18	813 1.1×	460 1.0×	225 0.5×	407 1.5×	212 0.9×	37	1.3k
KJ Trainor Australia	14	756 1.0×	528 1.2×	360 0.8×	427 1.6×	338 1.4×	19	1.6k
Ingrid Simonitsch Austria	22	498 0.6×	357 0.8×	361 0.8×	244 0.9×	327 1.4×	54	1.4k
Kenkichi Kita Japan	18	622 0.8×	559 1.2×	434 1.0×	276 1.0×	173 0.7×	57	1.2k
WC Chan United States	19	959 1.2×	718 1.6×	707 1.6×	405 1.5×	219 0.9×	26	1.6k
K. F. Wong China	20	689 0.9×	528 1.2×	508 1.2×	254 1.0×	146 0.6×	55	1.3k
MF Martelli Italy	15	544 0.7×	376 0.8×	506 1.2×	214 0.8×	229 0.9×	30	1.2k
RK Brynes United States	19	555 0.7×	451 1.0×	375 0.9×	325 1.2×	119 0.5×	37	1.2k
E. Condé Spain	21	1.1k 1.5×	943 2.1×	314 0.7×	452 1.7×	164 0.7×	43	1.7k

Countries citing papers authored by DY Mason

Since Specialization

Citations

This map shows the geographic impact of DY Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DY Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DY Mason more than expected).

Fields of papers citing papers by DY Mason

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DY Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DY Mason. The network helps show where DY Mason may publish in the future.

Co-authorship network of co-authors of DY Mason

This figure shows the co-authorship network connecting the top 25 collaborators of DY Mason. A scholar is included among the top collaborators of DY Mason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DY Mason. DY Mason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Tedoldi, Sara, J L Cordell, Soo‐Yong Tan, et al.. (2006). Jaw1/LRMP, a germinal centre‐associated marker for the immunohistological study of B‐cell lymphomas. The Journal of Pathology. 209(4). 454–463. 33 indexed citations

2.

Pittaluga, Stefania, Karen Pulford, Iwona Włodarska, et al.. (1997). ALK-1 antibody staining pattern in anaplastic large cell lymphoma (ALCL) and ALCL-Hodgkin's like. Laboratory Investigation. 76(1). 768–768. 2 indexed citations

3.

Pulford, Karen, Nathalie Lecointe, Karen Leroy, et al.. (1995). Expression of TAL-1 proteins in human tissues. Blood. 85(3). 675–684. 106 indexed citations

4.

Mason, DY, J L Cordell, Jannie Borst, et al.. (1995). CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples. Blood. 86(4). 1453–1459. 141 indexed citations

5.

Buccheri, Valéria, Biljana Mihaljević, E Matutes, et al.. (1993). mb-1: a new marker for B-lineage lymphoblastic leukemia. Blood. 82(3). 853–857. 44 indexed citations

6.

Buccheri, Valéria, Biljana Mihaljević, E Matutes, et al.. (1993). mb-1: a new marker for B-lineage lymphoblastic leukemia. Blood. 82(3). 853–857. 37 indexed citations

7.

Pezzella, Francesco, Margaret T. Jones, Elisabeth Ralfkiær, et al.. (1992). Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma. British Journal of Cancer. 65(1). 87–89. 81 indexed citations

8.

Falini, Brunangelo, Stefano Pileri, MF Martelli, et al.. (1990). Peripheral T-cell lymphoma associated with hemophagocytic syndrome [see comments]. Blood. 75(2). 434–444. 122 indexed citations

9.

Nacheva, E, et al.. (1988). A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor beta-chain gene. Blood. 72(1). 234–240. 7 indexed citations

10.

Fischer, Peter, Elisabeth P. Nacheva, DY Mason, et al.. (1988). A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor beta-chain gene. Blood. 72(1). 234–240. 181 indexed citations

11.

Mason, DY, et al.. (1987). Value of monoclonal anti-CD22 (p135) antibodies for the detection of normal and neoplastic B lymphoid cells. Blood. 69(3). 836–840. 7 indexed citations

12.

Stein, H, DY Mason, Johannes Gerdes, et al.. (1985). The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood. 66(4). 848–858. 568 indexed citations breakdown →

13.

Mason, DY. (1981). Hodgkin's and Non-Hodgkin's Lymphomas. Journal of Clinical Pathology. 34(8). 941.5–941. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact